DT
Dualitas Therapeutics, Inc.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$32.6Msold at filing
Total offering$66.6M$34M still open
Investors in the raise7count reported to the SEC
FiledNov 18, 2025first sale Jul 7, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Thomas HudsonDirector
Forbes HuangExecutive Officer
Alicia LeveyDirector
Michael RossDirector
Greg LazarExecutive Officer
Neil WeirDirector
Mark McDadeDirector
Richard MurrayExecutive Officer, Director
Nikola TrbovicDirector
Executive officers, directors and promoters as listed on the Form D.